VincentJL. Nosocomial infection in adult intensive-care units. Lancet2003;361: 2068–77.
2.
EORTC International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infections in febrile granulocytopenic patients with cancer. J Infect Dis1978;137: 14–29.
3.
TorresARelloJ. Update in community-acquired and nosocomial pneumonia. 2009. Am J Respir Crit Care Med2010;181: 782–87.
4.
AdibconquyMCavaillonJ. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett2007;581: 3723–33.
5.
Huber-LangMSYounkinEMSarmaJV. Complement-induced impairment of innate immunity during sepsis. J Immunol2002;169: 3223–31.
6.
FlierlMAPerlMRittirschD. The role of C5a in the innate immune response after experimental blunt chest trauma. Shock2007;29: 25–31.
7.
OppermannMGötzeO. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors. Immunology1994;82: 516–21.
8.
MorrisA ConwayKefalaKWilkinsonT. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med2009;180: 19–28.
9.
DöckeWDRandowFSyrbeU. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med1997;3: 678–81.
10.
VenetFChungC-SKheroufH. Increased circulating regulatory T cells contribute to lymphocyte anergy in septic shock patients. Intensive Care Med2009;35: 678–86.
11.
MorrisA ConwayKefalaKWilkinsonTS. Diagnostic importance of pulmonary interleukin-1 beta and interleukin-8 in ventilator-associated pneumonia. Thorax2010;65: 201–07.
12.
MorrisA ConwayKefalaKO'KaneC. Ventilator-associated pneumonia is characterised by elevated neutrophil proteases. (Abstract (oral presentation), ICS State of the Art Meeting 2009). JICS2010;11: 58–59.
13.
MorrisA ConwayRossiAGWalshTSSimpsonAJ. C5a drives phagocytic dysfunction via a PI3K delta-dependent inhibition of actin polymerization. (Abstract, ICS State of the Art Meeting 2009). JICS2010;11: 61.
14.
MorrisA ConwayRossiAGWalshTSSimpsonAJ. Inhibition of Rho-A by C5a leads to defective neutrophil phagocytosis in critically ill patients. (Abstract (oral presentation), ESICM Annual Congress2010). Intensive Care Med in press.
15.
MorrisA ConwayAntonelliJBrittanM. C5a mediated neutrophil dysfunction precedes and predicts nosocomial infection in critical illness. (Abstract, ESICM Annual Congress 2010). Intensive Care Med in press.
16.
CailleVChicheJ-DNciriN. Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock. Shock2004;22: 521–26.
17.
MorrisA ConwayBrittanMAntonelliJ. Immuno-suppressive regulatory (CD4+CD25+FOXP3+) T-cells are elevated in septic and non-septic critical illness. Abstract submitted for ICS State of the Art Meeting 2010.
18.
MorrisA ConwayBrittanMAntonelliJ. Combined immuno-phenotyping of neutrophils, monocytes and T-cells enables accurate prediction of the risk of nosocomial infection. Abstract submitted for ICS State of the Art Meeting 2010.
19.
NaeijeR and BrimioulleS. Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure. Crit Care2001;5: 67–71.
20.
SenturkM. New concepts of the management of one-lung ventilation. Curr Opin Anaesthesiol2006;19: 1–4.
ChaouatABugnetASKadaouiN. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med2005;172: 189–94.
23.
McLaughlinVV and McGoonMD. Pulmonary arterial hypertension. Circulation2006;114: 1417–31.
24.
SmithTGRobbinsPARatcliffePJ. The human side of hypoxia-inducible factor. Br J Haematol2008;141: 325–34.
25.
SmithTGBrooksJTBalanosGM. Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med2006;3: 1178–85.
26.
SmithTGBrooksJTBalanosGM. Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiology. In: Integration in Respiratory Control - from Genes to Systems. PoulinMJ and WilsonRJ, Eds. 2008, Springer Publishers: New York.
27.
SmithTGBishopTCarmelietP. The acute hypoxic ventilatory response is augmented in PHD2-deficient mice. Am J Resp Crit Care Med2008;177: A270.
28.
SmithTGBalanosGMCroftQP. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol2008;586: 5999–6005.
29.
SmithTGTalbotNPPrivatC. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA2009;302: 1444–50.
30.
JoynerMJ and JohnsonBD. Iron lung? New ideas about hypoxic pulmonary vasoconstriction. J Physiol2008;586: 5837–38.
31.
RodriguezRMCorwinHLGettingerA. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness?J Crit Care2001; 16: 36–41.
32.
MunozMRomeroAMoralesM. Iron metabolism, inflammation and anemia in critically ill patients. A cross-sectional study. Nutr Hosp2005;20: 115–20.
33.
SmithTGTalbotNP. Prolyl hydroxylases and therapeutics. Antioxid Redox Signal2010;12: 431–33.
34.
NagelSTalbotNPMecinovicJSmithTG. Therapeutic manipulation of the HIF hydroxylases. Antioxid Redox Signal2010;12: 481–501.
35.
AngusDCLinde-ZwirbleWTLidickerJ. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med2001;29: 1303–10.
36.
Brun-BuissonC. The epidemiology of the systemic inflammatory response. Intensive Care Med2000;26 Suppl 1:S64–74.
37.
MartinGSManninoDMEatonS. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med2003;348: 1546–54.
38.
BoneRCBalkRACerraFB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest1992;101: 1644–55.
39.
MacCallumNSGordonSEQuinlanGJ. Abstract 23: The Systemic Inflammatory Response Syndrome Following Cardiac Surgery. Circulation2007;116 (16_MeetingAbstracts):II_928-.
40.
Brun-BuissonCMeshakaPPintonP. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med2004;30: 580–88.
41.
PadkinAGoldfradCBradyAR. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med2003;31: 2332–38.
42.
DasUN. Critical advances in septicemia and septic shock. Crit Care2000;4: 290–96.
43.
MarshallJC. Neutrophils in the pathogenesis of sepsis. Crit Care Med2005;33(12 Suppl):S502–5.
44.
MacCallumNSQuinlanGJEvansTW. The role of neutrophil-derived myeloperoxidase in organ dysfunction and sepsis. In: VincentJL, ed. Yearbook of Intensive Care and Emergency Medicine: Springer: 2007;173–78.
45.
WeissSJLampertMBTestST. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science1983;222: 625–28.
46.
PullarJMVissersMCWinterbournCC. Living with a killer: the effects of hypochlorous acid on mammalian cells. IUBMB Life2000;50: 259–66.
47.
VissersMCPullarJMHamptonMB. Hypochlorous acid causes caspase activation and apoptosis or growth arrest in human endothelial cells. Biochem J1999;344Pt 2: 443–49.
48.
GriffinSVChapmanPTLianosEA. The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney Int1999;55: 917–25.
49.
SegelmarkMPerssonBHellmarkT. Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?Clin Exp Immunol1997;108: 167–74.
50.
BakerCSEvansTWHaslamPL. Measurement of ceruloplasmin in the lungs of patients with acute respiratory distress syndrome: is plasma or local production the major source?Respiration2000;67: 533–38.
51.
FestaMMumbySNadelS. Antioxidant protection against iron in children with meningococcal sepsis. Crit Care Med2002;30: 1623–29.
52.
GutteridgeJMQuinlanGJMumbyS. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins. J Lab Clin Med1994;124: 263–73.
53.
PepperJRMumbySGutteridgeJM. Sequential oxidative damage, and changes in iron-binding and iron-oxidising plasma antioxidants during cardiopulmonary bypass surgery. Free Radic Res1994;21: 377–85.
54.
VincentJLMorenoRTakalaJ. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med1996;22: 707–10.
55.
Peroxidase activity of hemoproteins released into plasma as sources of oxidative stress in sepsis: a preliminary report. A60. Annual Congress Society of Critical Care Medicine; 2007; Orlando, FL, USA. SCCM.
ClaessonRKarlssonMZhangY. Relative role of chloramines, hypochlorous acid, and proteases in the activation of human polymorphonuclear leukocyte collagenase. J Leukoc Biol1996;60: 598–602.
58.
ArnholdJ. Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc)2004;69: 4–9.
59.
EiserichJPBaldusSBrennanML. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science2002;296: 2391–94.
60.
MidwinterRGVissersMCWinterbournCC. Hypochlorous acid stimulation of the mitogenactivated protein kinase pathway enhances cell survival. Arch Biochem Biophys2001;394: 13–20.
61.
SchoonbroodtSLegrand-PoelsSBest-BelpommeM. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem J1997;321 (Pt 3):777–85.
62.
SchildknechtSUllrichV. Peroxynitrite as regulator of vascular prostanoid synthesis. Arch Biochem Biophys2009;484: 183–89.
63.
EvansTJButteryLDCarpenterA. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA1996;93: 9553–58.
64.
SengelovHKjeldsenLBorregaardN. Control of exocytosis in early neutrophil activation. J Immunol1993;150: 1535–43.
65.
MarchettiCPatriarcaPSoleroGP. Genetic characterization of myeloperoxidase deficiency in Italy. Hum Mutat2004;23: 496–505.
66.
NauseefWMRootRKMalechHL. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest1983;71: 1297–307.
67.
GalijasevicSMaitraDLuT. Myeloperoxidase interaction with peroxynitrite: chloride deficiency and heme depletion. Free Radic Biol Med2009; In Press, Corrected Proof.
68.
ChapmanALHamptonMBSenthilmohanR. Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J Biol Chem2002;277: 9757–62.
69.
ZhangRShenZNauseefWM. Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma. Blood2002;99: 1802–10.
70.
ParkYSSuzukiKMumbyS. Antioxidant binding of caeruloplasmin to myeloperoxidase: myeloperoxidase is inhibited, but oxidase, peroxidase and immunoreactive properties of caeruloplasmin remain intact. Free Radic Res2000;33: 261–65.
AndrewsPCKrinskyNI. A kinetic analysis of the interaction of human myeloperoxidase with hydrogen peroxide, chloride ions, and protons. J Biol Chem1982;257: 13240–45.
73.
WinterbournCC. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology2002;181–82: 223–27.
74.
PascualCKarzaiWMeier-HellmannA. A controlled study of leukocyte activation in septic patients. Intensive Care Med1997;23: 743–48.
75.
DowdyDWEidMPSedrakyanA. Quality of life in adult survivors of critical illness: a systematic review of the literature. Intensive Care Med2005;31: 611–20.
76.
JacksonJCHartRPGordonSM. Post-traumatic stress disorder and post-traumatic stress symptoms following critical illness in medical intensive care unit patients: assessing the magnitude of the problem. Crit Care2007;11: R27.
77.
GranbergAEngbergIBLundbergD. Patients' experience of being critically ill or severely injured and cared for in an intensive care unit in relation to the ICU syndrome. Part 1. Intensive Crit Care Nursing1998;14: 294–307.
78.
National Institute for Health and Clinical Excellence. Clinical Guideline 83: Rehabilitation after critical illness. NICE2009.
79.
BaronRMKennyDA. The moderator-mediator variable distinction in social psychological research. J Personality Social Psychol1986;51: 1173–82.
80.
WareJESherbourneCD. The MOS 36-item short-form health survey(SF-36). 1. Conceptual framework and item selection. Medical Care1992;6: 473–83.
81.
PearseRMHarrisonDAJamesP. Identification and characterisation of the high-risk surgical population in the United Kingdom. Crit Care2006;10: R81.
82.
KhuriSFHendersonWGDePalmaRG. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg2005;242: 326–41; discussion 341–23.
83.
JhanjiSPearseRM. The use of early intervention to prevent postoperative complications. Curr Opin Crit Care2009;15: 349–54.
84.
VignaliAGianottiLBragaM. Altered microperfusion at the rectal stump is predictive for rectal anastomotic leak. Dis Colon Rectum2000;43: 76–82.
85.
MiyazakiTKuwanoHKatoH. Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J Surg2002;26: 1319–23.
86.
PearseRDawsonDFawcettJ. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445]. Crit Care2005;9: R687–693.
87.
WilsonJWoodsIFawcettJ. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery?BMJ1999; 318: 1099–103.
88.
BoydOGroundsRMBennettED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA1993;270: 2699–707.
89.
De BackerDCreteurJPreiserJC. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med2002;166: 98–104.
90.
RiversENguyenBHavstadS. Early goal-directed therapy in the treatment of severe sepsis and septic shock?N Engl J Med2001; 345: 1368–77.
91.
LandryDWOliverJA. The pathogenesis of vasodilatory shock. N Engl J Med2001;345: 588–95.
92.
DellingerRPLevyMMCarletJM. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008?Crit Care Med2008; 36: 296–27.
93.
BrealeyDBrandMHargreavesI. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet2002;360: 219–23.
94.
CrouserED. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion2004;4: 729–41.
95.
BrealeyDKaryampudiSJacquesTS. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure?Am J Physiol Regul Integr Comp Physiol2004; 286: R491–497.
96.
CallahanLASupinskiGS. Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med2005;172: 861–68.
97.
LanoneSTailléCBoczkowskiJ. Diaphragmatic fatigue during sepsis and septic shock?Intensive Care Med2005; 31: 1611–17.
98.
DuchenMR. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med2004;25: 365–451.
99.
MartynDAGordonAM. Force and stiffness in glycreated rabbit psoas fibres. Effect of calcium and elevated phosphate. J Gen Phsyiol1992;99: 795–816.
100.
BrownGC. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta2001;1504: 46–57.
101.
HadenDWSulimanHBCarrawayMS. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med2007;176: 768–77.
102.
BoczkowskiJLisderoCLLanoneS. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J1999;13: 1637–46.
103.
StevensEDFaulknerJA. The capacity of mdx mouse diaphragm muscle to do oscillatory work. J Physiol2000;522: 457–66.
104.
DuchenMRSurinAJacobsonJ. Imaging mitochondrial function in intact cells. Meth Enzymol2003;361: 353–89.
105.
ParkerNAffourtitCVidal-PuigA. Energization-dependant endogenous activation of proton conductance in skeletal muscle mitochondria. Biochem J2008;412: 131–39.
106.
KreymannGGrosserSBuggischP. Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome and septic shock. Critical Care Med1993;21: 1012–19.
107.
BotaD PeresLopes FerreiraFMelotC. Body temperature alterations in the critically ill. Intensive Care Med2004;30: 811–16.
108.
CallahanLAStofanDASzwedaLI. Free radicals alter maximal diaphragmatic mitochondrial oxygen consumption in endotoxin-induced sepsis. Free Radic Biol Med2001;30: 129–38.
109.
FriedrichO. Critical illness myopathy: what is happening?Curr Opin Clin Nutr Metab Care2006;9: 403–09.
110.
ZinkWKaessMHoferS. Alterations in intracellular Ca2+-homeostasis of skeletal muscle fibers during sepsis*. Critical Care Med2008;36: 1559–63.
111.
MorrisA ConwayKefalaKWilkinsonTS. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med2009;180: 19–28.
112.
CailleVChicheJ-DNciriN. Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock. Shock2004;22: 521–26.
113.
HebertPCWellsGBlajchmanMA. A multicentre, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med1999;340: 409–17.
114.
VincentJLBaronJFReinhartK. Anemia and blood transfusion in critically ill patients. JAMA2002;288: 1499–507.
115.
CorwinHLGettingerAPearlRG. The CRIT Study: Anemia and blood transfusion in the critically ill – Current clinical practice in the United States. Crit Care Med2004;32: 39–52.
116.
SakrYLoboSKnuepferS. Anemia and blood transfusion in a surgical intensive care unit. Crit Care2010;14: R92.
117.
WalshTSStanworthSJPrescottRJ. Prevalence, management and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med2010; in press.
118.
FerreiraFLBotaDP. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA2001;285: 1754–58.
119.
VincentJLSakrYSprungC. Are blood transfusions associated with greater mortality rates?Anesthesiology2008;108: 31–39.
120.
SakrYLoboSKnuepferS. Anemia and blood transfusion in a surgical intensive care unit. Crit Care2010;14: R92.
121.
WalshTSStanworthSJPrescottRJ. Prevalence, management and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med2010; In Press.
122.
WalshTSSalehE-E-D. Anaemia during critical illness. Bri J Anaesthesia2006;97: 278–91.
123.
ChantCWilsonGFriedrichJO. Anemia, transfusion and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care2006;10: R140.
124.
WelchCHarrisonDShortARowanK. The increasing burden of alcoholic liver disease on United Kingdom critical care units: secondary analysis of a high quality clinical database. J Health Serv Res Policy2008;13 (Supp 2): 40–44.
125.
SICSAG report. Audit of critical care in Scotland reporting 2005–06; 2007 (Edinburgh: ISD).
126.
SICSAG report. Audit of critical care in Scotland reporting 2007; 2008 (Edinburgh: ISD).
UusaroAParviainenITenhunenJJRuokonenE. The proportion of intensive care unit admissions related to alcohol use: a prospective cohort study. Acta Anaesthesiol Scand2005;49: 1236–40.
130.
AzoulayEPochardFChevretSAdrieC. Half the family members of intensive care unit patients do not want to share in the decision-making process: a study in 78 French intensive care units. Crit Care Med2004;32: 1832–38.
131.
PochardFAzoulayEChevretSLemaireF. Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med2001;29: 1983–97.
132.
BenbenishtyJGanzFDLippertA. Nurse involvement in end-of-life decision making: the ETHICUS study. Intensive Care Med2006;32: 129–32.
133.
SprungCLWoodcockTSjokvistP. Reason, considerations, difficulties and documentation of end-of-life decisions in European intensive care units: the ETHICUS study. Intensive Care Med2008;34: 271–77.
VenetFChungC-SKheroufH. Increased circulating regulatory T cells contribute to lymphocyte anergy in septic shock patients. Intensive Care Med2009;35: 678–86.
136.
DalliJNorlingLVRenshawD. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood2008;15: 2512–19.
137.
LynchSFLudlamCA. Plasma microparticles and vascular disorders. Br J Haematol2007;137: 36–48.
MillerRFAllenECopasA. Improved survival of HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax2006;61: 716–21.
140.
DavisJLMorrisAKalletRH. Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury. Thorax2008;63: 988–93.
141.
JapiassuAM. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care2010: R152.
142.
BlackRRauchCKozloskyC. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature1997;385: 729–33.
143.
Alvarez-IglesiasAWayneGO'DeaKP. Continuous real-time measurement of tumour necrosis factor-a converting enzyme activity on live cells. Lab Invest2005;85: 1440–48.
144.
Novaes. Intensive Care Med1999;25: 1421–26.
145.
van de Leur. Crit Care2004;8: R467–R473.
146.
MartindaleRMcClaveSVanekV. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med2009. 37: 1757–61.
147.
ImhoffMKuhlsS. Alarm algorithms in critical care monitoring. Anesth Analg2006;102: 1525–37.
148.
MeredithCEdworthyJ. Are there too many alarms in the intensive care unit? An overview of the problems. J Adv Nurs1995;21: 15–20.
149.
BaloghDKittingerEBenzerAHacklJM. Noise in the ICU. Intensive Care Med1993;19: 343–46.